日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells

APC/PIK3CA突变和β-catenin状态可预测患者来源的结直肠癌细胞对tankyrase抑制剂的敏感性

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02484-8
Chen, Mingjue; Mashima, Tetsuo; Oishi, Taichi; Muramatsu, Yukiko; Seto, Yosuke; Takamatsu, Manabu; Kawata, Naomi; Morino, Shun; Nakamura, Ayane; Inaba, Saori; Yuan, Xunmei; Maruyama, Kohei; Suzuki, Mai; Sato, Ayana; Yoshida, Haruka; Jang, Myung-Kyu; Mizutani, Anna; Takeuchi, Kengo; Yamaguchi, Kensei; Shirai, Fumiyuki; Nagayama, Satoshi; Katayama, Ryohei; Seimiya, Hiroyuki
肿瘤
肠癌
肿瘤免疫
细胞生物学
APC
发表日期：2024
文献求助 收藏

Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer.

探索性研究发现基质金属蛋白酶-14 和 -9 可作为瑞戈非尼治疗转移性结直肠癌疗效的潜在生物标志物

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16162855
Suenaga Mitsukuni, Mashima Tetsuo, Kawata Naomi, Dan Shingo, Seimiya Hiroyuki, Yamaguchi Kensei
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer

靶向组蛋白H3K27乙酰化/BRD4依赖性ALDH1A3诱导治疗胃癌早期耐药性

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-23-0639
Lee, Jin; Mashima, Tetsuo; Kawata, Naomi; Yamamoto, Noriko; Morino, Shun; Inaba, Saori; Nakamura, Ayane; Kumagai, Koshi; Wakatsuki, Takeru; Takeuchi, Kengo; Yamaguchi, Kensei; Seimiya, Hiroyuki
胃癌
肿瘤
表观遗传
肿瘤免疫
BRD4
ALDH
乙酰化
发表日期：2024
文献求助 收藏

Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients

CCR5通路中潜在的分子串扰可预测转移性结直肠癌患者对瑞戈非尼的反应

期刊:Cancer Genomics & Proteomics
影响因子:2.6
doi:10.21873/cgp.20262
Suenaga, Mitsukuni; Zhang, W U; Mashima, Tetsuo; Schirripa, Marta; Cao, Shu; Okazaki, Satoshi; Berger, Martin D; Miyamoto, Yuji; Barzi, Afsaneh; Yamaguchi, Toshiharu; Lenz, Heinz-Josef
肿瘤
CCR5
肠癌
肿瘤免疫
信号转导
发表日期：2021
文献求助 收藏

Meeting report of the 14th Japan-Korea joint symposium on cancer and aging research: current status of translational research and approaches to precision medicine

第十四届日韩癌症与衰老研究联合研讨会会议报告：转化研究现状及精准医学方法

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-019-02887-2
Sueoka, Eisaburo; Watanabe, Tatsuro; Mashima, Tetsuo; Shirakami, Yohei; Komori, Atsumasa; Matsuo, Keitaro; Yoshikawa, Hiroshi Y; Cho, Kyung A; Park, Tae Jun; Seimiya, Hiroyuki; Kim, Eung-Gook; Suganuma, Masami; Chung, Junho
肿瘤
衰老
肿瘤免疫
发表日期：2019
文献求助 收藏

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer

针对既往接受过治疗的KRAS外显子2野生型结直肠癌，开展每两周一次的西妥昔单抗联合伊立替康作为三线治疗方案的II期临床试验

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.13698
Osumi, Hiroki; Shinozaki, Eiji; Mashima, Tetsuo; Wakatsuki, Takeru; Suenaga, Mitsukuni; Ichimura, Takashi; Ogura, Mariko; Ota, Yumiko; Nakayama, Izuma; Takahari, Daisuke; Chin, Keisho; Miki, Yoshio; Yamaguchi, Kensei
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2018
文献求助 收藏

Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib

CCL5/CCR5通路基因多态性作为转移性结直肠癌患者接受瑞戈非尼治疗后预后及手足皮肤反应的遗传生物标志物

期刊:Clinical Colorectal Cancer
影响因子:3.2
doi:10.1016/j.clcc.2018.02.010
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Cremolini, Chiara; Antoniotti, Carlotta; Borelli, Beatrice; Mashima, Tetsuo; Okazaki, Satoshi; Berger, Martin D; Miyamoto, Yuji; Gopez, Roel Jr; Barzi, Afsaneh; Lonardi, Sara; Yamaguchi, Toshiharu; Falcone, Alfredo; Loupakis, Fotios; Lenz, Heinz-Josef
肿瘤
CCR5
肠癌
肿瘤免疫
CCL5
信号转导
发表日期：2018
文献求助 收藏

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer

mTOR信号通路介导Wnt驱动的结直肠癌对tankyrase抑制剂的耐药性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.18146
Mashima, Tetsuo; Taneda, Yoko; Jang, Myung-Kyu; Mizutani, Anna; Muramatsu, Yukiko; Yoshida, Haruka; Sato, Ayana; Tanaka, Noritaka; Sugimoto, Yoshikazu; Seimiya, Hiroyuki
肿瘤
肠癌
mTOR
肿瘤免疫
信号转导
Wnt/β-Catenin
发表日期：2017
文献求助 收藏

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.

血清 VEGF-A 和 CCL5 水平作为瑞戈非尼治疗转移性结直肠癌患者疗效和毒性的候选生物标志物

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.9187
Suenaga Mitsukuni, Mashima Tetsuo, Kawata Naomi, Wakatsuki Takeru, Horiike Yuki, Matsusaka Satoshi, Dan Shingo, Shinozaki Eiji, Seimiya Hiroyuki, Mizunuma Nobuyuki, Yamaguchi Kensei, Yamaguchi Toshiharu
肿瘤
肠癌
肿瘤免疫
发表日期：2016
文献求助 收藏

Development of a gene expression database and related analysis programs for evaluation of anticancer compounds

开发基因表达数据库及相关分析程序，用于评估抗癌化合物

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.12071
Ushijima, Masaru; Mashima, Tetsuo; Tomida, Akihiro; Dan, Shingo; Saito, Sakae; Furuno, Aki; Tsukahara, Satomi; Seimiya, Hiroyuki; Yamori, Takao; Matsuura, Masaaki
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏